Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D006710 |
Homocysteine |
Homocysteine results in decreased expression of MSH6 mRNA | decreases expression | 17326132
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MSH6 mRNA | decreases expression | 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of MSH6 mRNA | decreases expression | 15336504
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of MSH6 mRNA | decreases expression | 16404146
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of MSH6 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSH6 mRNA | affects cotreatment|increases expression | 17942748
|
D005038 |
Ethylnitrosourea |
MSH6 gene mutant form results in decreased susceptibility to Ethylnitrosourea | decreases response to substance | 18522974
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of MSH6 gene | increases mutagenesis | 18417481 16495775
|
C106014 |
gedunin |
gedunin results in decreased expression of MSH6 mRNA | decreases expression | 17010675
|
C015329 |
lycopene |
lycopene results in increased expression of MSH6 mRNA | increases expression | 16886892
|
D008345 |
Manganese |
Manganese results in decreased expression of MSH6 mRNA | decreases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in decreased expression of MSH6 mRNA | decreases expression | 17175027
|
D008770 |
Methylnitrosourea |
MSH6 gene mutant form results in decreased susceptibility to Methylnitrosourea | decreases response to substance | 18522974
|
D008770 |
Methylnitrosourea |
Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] | affects binding|increases reaction | 16204460
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of MSH6 mRNA | increases expression | 19270015
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of MSH6 mRNA | decreases expression | 18445702
|
C064116 |
S-(1,1,2,2-tetrafluoroethyl)cysteine |
S-(1,1,2,2-tetrafluoroethyl)cysteine results in decreased expression of MSH6 mRNA | decreases expression | 16678137
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of MSH6 mRNA | decreases expression | 16014739
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of MSH6 protein | increases expression | 19072884
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MSH6 mRNA | affects cotreatment|increases expression | 17942748
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of MSH6 mRNA | decreases expression | 17951470
|
C050414 |
tripterine |
tripterine results in decreased expression of MSH6 mRNA | decreases expression | 17010675
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.18 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.18 | 14514962 15322242 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.91 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.08 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
7.16 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.16 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
7.16 | 15688392 15113128 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.69 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
17.09 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
17.09 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.09 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.67 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.87 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.50 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.91 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
10.89 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
10.89 | 16910769 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.42 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.64 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Homocysteine |
3.04 | 20468076 16297937 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.63 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.63 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.73 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.67 | 14601052 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.84 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
8.96 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
8.96 | 16357521 16651633 18412241 16436596 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.01 | 15668708 19526202 15993339 17426702 18234424 15567936 18382427 15136595 15994142 18695136 16935488 16264153 16096432 15939500 16595493 15692762 17369602 11325840 18628466 16115903 15634643 16826403 17983394 16322301 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
2.01 | 16253758 14633655 11306469 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
OMIM:604370 |
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1 |
marker/mechanism |
|
| |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.78 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.76 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.63 | 17876044 18059187 16023760 16234567 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
4.63 | 17173139 1701930 6705139 20007298 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.63 | 17306315 15276417 16507464 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.14 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
4.77 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.77 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.34 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.50 | 15792986 17351982 17924179 18627295 15811867 17329180 16612575 15505089 16455267 16364871 17007740 17519947 16242529 16278810 17382496 16109756 16269455 15476868 16731534 17974986 16952015 17131338 17308081 16651473 17928571 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.93 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
3.96 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.87 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
15.87 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
15.87 | 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.87 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.21 | 4080065 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.96 | 17160924 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.63 | 16919318 17110522 17681005 15861022 16105132 17333356 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.63 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D003123 |
Colorectal Neoplasms, Hereditary Nonpolyposis |
marker/mechanism |
|
| 18417481 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.02 | 14669216 17141729 |
MESH:D003324 |
Coronary Artery Disease |
|
Homocysteine |
3.74 | 16379339 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 10048152 20055451 15322242 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.40 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.66 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
3.83 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.83 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.00 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.00 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.96 | 1851702 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.96 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.40 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.40 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.87 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.15 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
marker/mechanism |
|
| |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.42 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.98 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.13 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.07 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.84 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.87 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.50 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.21 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.98 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.06 | 20426865 |
MESH:D017889 |
Exfoliation Syndrome |
|
Homocysteine |
5.67 | 16504073 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.41 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.41 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.42 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.55 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
5.20 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.91 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.64 | 16452187 |
MESH:D005901 |
Glaucoma |
|
Homocysteine |
5.25 | 16504073 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
11.96 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
11.96 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
11.96 | 17043766 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
6.55 | 16357521 16651633 18412241 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
6.55 | 9825942 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.57 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.50 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Homocysteine |
6.87 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.87 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.45 | 16144979 16244372 16330681 18006777 17888722 16495754 12587719 16879835 16244371 17875725 18674790 14766674 16707910 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
6.96 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.96 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.86 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.29 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
14.16 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
14.16 | 19772884 19176532 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
14.16 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
7.35 | 17606976 15147373 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
7.35 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.02 | 16354765 15340226 18606429 8697196 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.14 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Homocysteine |
4.67 | 17292331 18234410 17369066 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.89 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.77 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.42 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.14 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
11.14 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.14 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.83 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.60 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.29 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.19 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.19 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.11 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
3.89 | 17379185 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.13 | 16085563 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
4.17 | 15526292 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
2.87 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.41 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.41 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.41 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.16 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
10.55 | 19073162 19482888 15975961 8742319 19812893 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.55 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.55 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.55 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
9.70 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.70 | 17172636 2563599 1399818 18308698 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.70 | 12151625 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.42 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.14 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
6.57 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
6.57 | 17703301 16271038 6695378 16019985 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
6.57 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.57 | 19931552 16712894 17077188 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.57 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
12.60 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
12.60 | 15790496 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
12.60 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
4.73 | 14633661 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.75 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
11.56 | 15621674 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
11.56 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
10.09 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
10.09 | 10767621 18041768 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
10.09 | 16944150 16827153 17131329 15113128 12931682 15313902 10838139 16051031 14999141 19196723 15688392 14633655 17020996 11751437 10767621 16619500 11807958 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
5.49 | 19453300 16551646 16568477 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.44 | 16827129 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.44 | 19082730 16487513 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.96 | 17943659 |
MESH:D008591 |
Meningomyelocele |
|
Homocysteine |
5.50 | 16602021 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.04 | 17638057 |
OMIM:276300 |
MISMATCH REPAIR CANCER SYNDROME |
marker/mechanism |
|
| |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.46 | 15792986 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.97 | 16551646 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.75 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.47 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
9.50 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Homocysteine |
9.50 | 17412321 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
9.50 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.98 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.91 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.44 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
2.93 | 18259882 |
MESH:D009369 |
Neoplasms |
|
lycopene |
11.79 | 17051425 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
11.79 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.79 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.79 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
15.24 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
15.24 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
15.24 | 20056578 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.73 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.96 | 15640375 16889571 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.24 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.17 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.11 | 12854658 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
13.16 | 16003739 17160924 16651423 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
13.16 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.24 | 15555623 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.80 | 20558911 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.96 | 17160924 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.33 | 17016548 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.08 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.42 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
5.55 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.55 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.65 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Homocysteine |
5.95 | 16275827 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
5.95 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.43 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.22 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.13 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.13 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.52 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
3.58 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.16 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
2.21 | 16888761 16729912 16868541 15897917 15749863 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
2.21 | 17337101 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.21 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.21 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.28 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.47 | 12752131 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.18 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.36 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.80 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
4.38 | 18172121 18155124 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.45 | 11555667 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.95 | 17710206 15625365 15675481 16767912 18313854 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.20 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.75 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Homocysteine |
3.10 | 16641680 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.66 | 4039156 16876388 11442880 3137016 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.79 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.41 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.41 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.41 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.41 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.53 | 16767912 17203757 15625365 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.91 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.76 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
2.69 | 16257854 15930296 18593901 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.58 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.11 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
12.18 | 15790496 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
12.18 | 11418001 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.87 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
11.95 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
11.95 | 7505956 3078959 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
11.95 | 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.21 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.21 | 16452187 16712894 17306315 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.73 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.26 | 14692618 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.39 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.57 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.50 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.18 | 17638931 17334414 16364871 17678736 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.22 | 15886252 |